Navigation Links
Women Testing Negative for Familial Breast Cancer Gene Still at Increased Risk

Women testing negative for the two inherited breast cancer genes are still at increased risk of developing the disease, suggests research published// ahead of print in the Journal of Medical Genetics.

They should be regularly screened from 35 or 40 onwards, say the authors.

The research team assessed the families of 277 women in whom faults in the breast cancer genes BRCA1 and BRCA2 had been identified.

Faults in these genes account for only around 5% of all diagnosed breast cancers in developed countries. But they substantially increase a woman’s chances of developing early breast and/or ovarian cancer compared with the general population, and “predictive” testing is usually offered to other blood relatives.

Of the 277 women, 190 had breast cancer, 48 had ovarian cancer, and 33 had both. Six were free of the disease.

Among the 531 living female relatives who were tested for the genetic faults, almost half (49%) tested negative. Of these, 28 developed breast cancer and four developed ovarian cancer.

Among the 184 first degree relatives testing negative, 4 different BRCA1 and 2 “phenocopies” were identified, accounting for around one in four test results.

A phenocopy is when a patient develops the condition that a particular gene predisposes them to, but they test negative for the inherited genetic fault. This is likely to be due to other genetic variants (modifier genes) that mimic the physiological changes produced by that specific gene fault.

Thirteen of 107 first degree relatives with breast cancer and a family history of BRCA genes tested negative for these genetic faults.

On the basis of their findings, the authors calculated that first degree relatives testing negative for BRCA1 and 2 had around three times the risk of developing breast cancer by the age of 50 as the general population.

Environmental factors, such as diet, or hormones c ould account for some of the increased risk, but these are only likely to account for around 10% of familial cancers, say the authors.

“If confirmed, these findings have serious implications for the management of these people,” say the authors. They cite recent US guidelines, which recommend that women with a five year chance of developing breast cancer of more than 1.7% should be screened for breast cancer from the age of 35 onwards.

Recent guidance from the National Institute of Health and Clinical Excellence (NICE) in the UK recommends that women with a 10 year risk of 3% should be screened from the age of 40.

In this study, the women testing negative for the inherited genes had 6.4% chance of developing the disease by the age of 50. UK guidance currently states that women testing negative for the genes carry the same risk as the general population.

Source-NewswiseSRM
'"/>




Related medicine news :

1. Women suffer from sexual dysfunction too
2. Women find difficulty in calling it Quits
3. Women recognise faces better
4. Women more susceptible to brain damage from ecstasy
5. Good News For Women With Gestational Diabetes
6. Unsatisfactory Grade On Womens Health Issues
7. Risk for Pregnant Women
8. Womens strong sense of smell
9. Women need to exercise more to prevent obesity
10. Women benefit from consuming fish
11. Women are at risk with raised cholesterol
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... ... 2017 , ... The International Essential Tremor Foundation (IETF) will host a free ... The seminar will take place on Saturday, Aug. 26 at the Embassy Suites by ... run from 9 a.m. to 12 p.m., with check-in beginning at 8 a.m. The ...
(Date:7/24/2017)... ... 2017 , ... Axiad IDS , a leading provider of trusted identities ... WALLIX to expand its solution to help government contractors more quickly and cost-effectively ... ways to address the authentication requirements within NIST SP800-171, but no matter how ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... that already work hand-in-hand on an Innovation Collaboration program, have signed a five-year ... experience and cost of the care members and patients receive. The agreement also ...
(Date:7/24/2017)... ... July 24, 2017 , ... Puregraft, the global ... the issuance of United States Patent Number 9,695,398 (the '398 patent) and South ... The '398 and '324 patents cover methods and systems for optimizing fat grafts ...
(Date:7/24/2017)... ... 24, 2017 , ... The 2017 NCSL International Workshop & ... focuses on the new ISO/IEC 17025 standards. This marks the first time in ... calibration will be changed. , As an exhibitor, METTLER TOLEDO will showcase ...
Breaking Medicine News(10 mins):
(Date:7/24/2017)... , July 24, 2017  Diplomat Pharmacy, Inc. ... will release its second quarter 2017 operating results on ... conference call to follow at 5:00 p.m. ET. ... may listen to a live broadcast of the conference ... and referencing participant code 51641230 approximately 15 minutes prior ...
(Date:7/20/2017)... July 20, 2017  Prime Therapeutics LLC (Prime) released this ... M.D., following today,s Institute for Clinical and Economic Review,s (ICER) ... the effectiveness and value of abuse-deterrent formulations (ADF) of opioids. ... roundtable at the meeting. ... cost benefit to the use of abuse-deterrent formulations (ADF) in ...
(Date:7/14/2017)... 2017 It should come as no surprise to ... in the midst of a crippling opioid epidemic. According to ... number of overdose deaths from opiate-based medications has quadrupled, Says, ... million dead from 2001 to 2015". During this time, the ... similarly quadrupled, drawing a compelling link between prescription and eventual ...
Breaking Medicine Technology: